Navigating Racial Disparities in Psoriatic Arthritis: Insights From Patient-Reported Outcomes
FDA Approves Bimekizumab for Psoriatic Arthritis, Nonradiographic AxSpA, Ankylosing Spondylitis
Patients With AxSpA Have Complex Needs, Require Tailored Treatment
FDA Approves Benralizumab for Eosinophilic Granulomatosis With Polyangiitis
Join us as Dr. Iltefat Hamzavi shares insights into hidradenitis suppurativa. Learn about its signs, symptoms, differential diagnosis, and treatment strategies, as Dr. Hamzavi highlights the impact on patients and families.